Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.04p
   
  • Change Today:
      0.19p
  • 52 Week High: 2.50p
  • 52 Week Low: 0.23p
  • Currency: UK Pounds
  • Shares Issued: 1,029.60m
  • Volume: 99,194,108
  • Market Cap: £10.75m
  • RiskGrade: 747

Genedrive's Saudi Arabian distribution partner inks MoU with Ministry of Health

By Iain Gilbert

Date: Tuesday 28 Oct 2025

LONDON (ShareCast) - (Sharecast News) - Pharmacogenetic testing business Genedrive said on Tuesday that its exclusive distribution partner in the Kingdom of Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a memorandum of understanding with the Saudi Arabian Ministry of Health.
Genedrive said the scope of the MoU was to pilot its MT-RNR1 ID Kit for potential national implementation under a national initiative called, "Generations Hear".

The MOU was signed by Hatim Najjar, founder and chief executive of iDeal iDea, Dr Abdullah Al-Sohimi, General Director of Specialized Centers at Ministry of Health, and Dr Salem Baharoon, Deputy Minister for Therapeutic Services, Ministry of Health.

Dr Gino Miele, CEO of genedrive plc, said: "We are delighted with the signing of this MOU, which builds further on our commercial traction in Saudi Arabia and aligns perfectly to the long-term Saudi health goals. We are grateful to our valued partners at iDeal iDea for their support and look forward to progressing through pilot phase with the goal of implementation at national level."

As of 0825 GMT, Genedrive shares were up 15.17% at 0.51p.





Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 1.04p
Change Today 0.19p
% Change 22.82 %
52 Week High 2.50p
52 Week Low 0.23p
Volume 99,194,108
Shares Issued 1,029.60m
Market Cap £10.75m
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.70% above the market average18.70% above the market average18.70% above the market average18.70% above the market average18.70% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
96.28% below the market average96.28% below the market average96.28% below the market average96.28% below the market average96.28% below the market average
88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average88.57% below the sector average
Income Not Available
Growth
67.04% above the market average67.04% above the market average67.04% above the market average67.04% above the market average67.04% above the market average
88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average88.57% above the sector average

Genedrive Dividends

No dividends found

Trades for 31-Oct-2025

Time Volume / Share Price
16:35 18,151 @ 1.04p
16:35 18,151 @ 1.04p
16:29 334,322 @ 1.00p
16:29 201,005 @ 1.00p
16:28 1,000,000 @ 0.97p

Genedrive Key Personnel

CFO Russell Shaw
CEO Gino Miele

Top of Page